Cargando…
Chemosensitization of prostate cancer stem cells in mice by angiogenin and plexin-B2 inhibitors
Cancer stem cells (CSCs) are an obstacle in cancer therapy and are a major cause of drug resistance, cancer recurrence, and metastasis. Available treatments, targeting proliferating cancer cells, are not effective in eliminating quiescent CSCs. Identification of CSC regulators will help design thera...
Autores principales: | Li, Shuping, Goncalves, Kevin A., Lyu, Baiqing, Yuan, Liang, Hu, Guo-fu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6962460/ https://www.ncbi.nlm.nih.gov/pubmed/31942000 http://dx.doi.org/10.1038/s42003-020-0750-6 |
Ejemplares similares
-
Osteoclasts protect bone blood vessels against senescence through the angiogenin/plexin-B2 axis
por: Liu, Xiaonan, et al.
Publicado: (2021) -
Nanobody inhibitors of Plexin-B1 identify allostery in plexin–semaphorin interactions and signaling
por: Cowan, Richard, et al.
Publicado: (2023) -
Analysis of the interaction of Plexin-B1 and Plexin-B2 with Rnd family proteins
por: Wylie, Thomas, et al.
Publicado: (2017) -
Prostate cancer-derived angiogenin stimulates the invasion of prostate fibroblasts
por: Jones, Michelle L, et al.
Publicado: (2012) -
Opposing roles of PlexinA and PlexinB in axonal branch and varicosity formation
por: Neufeld, Shay Q, et al.
Publicado: (2011)